Tianqi Nie

Dr. Tianqi Nie

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YFYifei Fang
Yifei Fang
GLGuangze Li
Guangze Li
CHChunlin Huang
Chunlin Huang
KHKeqing Huang
Keqing Huang
YZYi Zhao
Yi Zhao
JWJun Wu
Jun Wu

2 September 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JZJunbo Zhao
Junbo Zhao
JDJiyuan Du
Jiyuan Du
YZYilu Zheng
Yilu Zheng
YFYifei Fang
Yifei Fang
JHJianlin Huang
Jianlin Huang
TNTianqi Nie
Tianqi Nie

30 November 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZFZhengwen Fang
Zhengwen Fang
LWLiying Wang
Liying Wang
XZXinyu Zhang
Xinyu Zhang
XPXiaohan Pei
Xiaohan Pei
LZLilin Zhou
Lilin Zhou
JWJun Wu
Jun Wu

11 April 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
XMXiaocong Ma
Xiaocong Ma
WFWeimin Fang
Weimin Fang
DWDuo Wang
Duo Wang
NSNiShao Shao
NiShao Shao
JCJifeng Chen
Jifeng Chen
ZXZeyu Xiao
Zeyu Xiao
Abnormal tumor vasculature and a hypoxic tumor microenvironment (TME) limit the effectiveness of conventional cancer treatment. Recent studies have shown that antivascular strategies that focus on antagonizing the hypoxic TME and promoting vessel normalization effectively synergize to increase the antitumor efficacy of conventional therapeutic regimens. By integrating multiple therapeutic agents, well-designed nanomaterials exhibit great advantages in achieving higher drug delivery efficiency and can be used as multimodal therapy with reduced systemic toxicity. In this review, strategies for the nanomaterial-based administration of antivascular therapy combined with other common tumor treatments, including immunotherapy, chemotherapy, phototherapy, radiotherapy, and interventional therapy, are summarized. In particular, the administration of intravascular therapy and other therapies with the use of versatile nanodrugs is also described. This review provides a reference for the development of multifunctional nanotheranostic platforms for effective antivascular therapy in combined anticancer treatments.

18 June 2025 in Trends in Biotechnology
Verified
Journal Article
Closed access
SGShuyi Gao
Shuyi Gao
TNTianqi Nie
Tianqi Nie
LJLinlan Jiang
Linlan Jiang
LWLiwen Wang
Liwen Wang
JWJun Wu
Jun Wu
YJYuenong Jiao
Yuenong Jiao

24 January 2026 in Acta Biomaterialia
Verified
Journal Article
Closed access
YCYishui Cai
Yishui Cai
TNTianqi Nie
Tianqi Nie
XLXi Luo
Xi Luo
YWYiqun Wu
Yiqun Wu
JWJun Wu
Jun Wu